Yu X - Search Results

1

Radiation-promoted CDC6 protein stability contributes to radioresistance by regulating senescence and epithelial to mesenchymal transition.

Yu X, Liu Y, Yin L, Peng Y, Peng Y, Gao Y, Yuan B, Zhu Q, Cao T, Xie B, Sun L, Chen Y, Gong Z, Qiu Y, Fan X, Li X. Yu X, et al. Oncogene. 2019 Jan;38(4):549-563. doi: 10.1038/s41388-018-0460-4. Epub 2018 Aug 29. Oncogene. 2019. PMID: 30158672 Free PMC article.

2

The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells.

Hou Y, Zhu Q, Li Z, Peng Y, Yu X, Yuan B, Liu Y, Liu Y, Yin L, Peng Y, Jiang Z, Li J, Xie B, Duan Y, Tan G, Gulina K, Gong Z, Sun L, Fan X, Li X. Hou Y, et al. Among authors: yu x. Cell Death Dis. 2017 Mar 9;8(3):e2659. doi: 10.1038/cddis.2017.53. Cell Death Dis. 2017. PMID: 28277541 Free PMC article.

3

FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription.

Liu Y, Liu Y, Yuan B, Yin L, Peng Y, Yu X, Zhou W, Gong Z, Liu J, He L, Li X. Liu Y, et al. Among authors: yu x. Oncotarget. 2017 Mar 7;8(10):17027-17037. doi: 10.18632/oncotarget.15224. Oncotarget. 2017. PMID: 28199985 Free PMC article.

4

FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness.

Yuan B, Liu Y, Yu X, Yin L, Peng Y, Gao Y, Zhu Q, Cao T, Yang Y, Fan X, Li X. Yuan B, et al. Among authors: yu x. Cell Death Dis. 2018 May 11;9(5):562. doi: 10.1038/s41419-018-0631-9. Cell Death Dis. 2018. PMID: 29752436 Free PMC article.

5

PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells.

Yin L, Liu Y, Peng Y, Peng Y, Yu X, Gao Y, Yuan B, Zhu Q, Cao T, He L, Gong Z, Sun L, Fan X, Li X. Yin L, et al. Among authors: yu x. J Exp Clin Cancer Res. 2018 Jul 16;37(1):153. doi: 10.1186/s13046-018-0810-7. J Exp Clin Cancer Res. 2018. PMID: 30012171 Free PMC article.

6

Correction to: PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/. BRCA1 DNA damage repair complex in prostate cancer cells.

Yin L, Liu Y, Peng Y, Peng Y, Yu X, Gao Y, Yuan B, Zhu Q, Cao T, He L, Gong Z, Sun L, Fan X, Li X. Yin L, et al. Among authors: yu x. J Exp Clin Cancer Res. 2022 Feb 22;41(1):72. doi: 10.1186/s13046-022-02290-9. J Exp Clin Cancer Res. 2022. PMID: 35193658 Free PMC article. No abstract available.

7

Chemosensitization of solid tumors by inhibition of Bcl-xL expression using DNAzyme.

Yu X, Yang L, Cairns MJ, Dass C, Saravolac E, Li X, Sun LQ. Yu X, et al. Oncotarget. 2014 Oct 15;5(19):9039-48. doi: 10.18632/oncotarget.1996. Oncotarget. 2014. PMID: 25344863 Free PMC article.

8

High mobility group box 3 promotes cervical cancer proliferation by regulating Wnt/β-catenin pathway.

Zhuang S, Yu X, Lu M, Li Y, Ding N, Ding Y. Zhuang S, et al. Among authors: yu x. J Gynecol Oncol. 2020 Nov;31(6):e91. doi: 10.3802/jgo.2020.31.e91. J Gynecol Oncol. 2020. PMID: 33078596 Free PMC article.

9

HuR Promotes Ovarian Cancer Cell Proliferation by Regulating TIMM44 mRNA Stability.

Yu X, Li Y, Ding Y, Zhang H, Ding N, Lu M. Yu X, et al. Cell Biochem Biophys. 2020 Dec;78(4):447-453. doi: 10.1007/s12013-020-00939-w. Epub 2020 Sep 8. Cell Biochem Biophys. 2020. PMID: 32901414

10

MiR-204 suppresses cell proliferation and promotes apoptosis in ovarian granulosa cells via targeting TPT1 in polycystic ovary syndrome.

Sun X, Su S, Zhang G, Zhang H, Yu X. Sun X, et al. Among authors: yu x. Biochem Cell Biol. 2019 Oct;97(5):554-562. doi: 10.1139/bcb-2019-0019. Epub 2019 Aug 28. Biochem Cell Biol. 2019. Retraction in: Biochem Cell Biol. 2023 Aug 1;101(4):378. doi: 10.1139/bcb-2023-0070 PMID: 31460785 Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34,757 results

Search Page

Filters